SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-164070
Filing Date
2018-05-15
Accepted
2018-05-15 16:05:46
Documents
55
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d576126d10q.htm 10-Q 520851
2 EX-31.1 d576126dex311.htm EX-31.1 9825
3 EX-31.2 d576126dex312.htm EX-31.2 9894
4 EX-32.1 d576126dex321.htm EX-32.1 5775
  Complete submission text file 0001193125-18-164070.txt   2513563

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aldx-20180331.xml EX-101.INS 350101
6 XBRL TAXONOMY EXTENSION SCHEMA aldx-20180331.xsd EX-101.SCH 32838
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aldx-20180331_cal.xml EX-101.CAL 39286
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aldx-20180331_def.xml EX-101.DEF 100176
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldx-20180331_lab.xml EX-101.LAB 273625
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldx-20180331_pre.xml EX-101.PRE 187397
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36332 | Film No.: 18836367
SIC: 2834 Pharmaceutical Preparations